| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4312a7b35719c8892121be20961aa1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_643b3e8f9dd8fccd938e975235b212df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1f88ccc41de51d6365f9a0460b85c32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114f8f0f5cba08e0c6acdca5a33baaba |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-10011 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate |
2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b59f3d700a513e0f12db3760c2a8a1eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82c6800fbbc24278a7a43e9bcc2f4814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9c5b1ffc6fd5542da27bd8ad76b2620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab42abd019479ee305fdb8e41fb3474 |
| publicationDate |
2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010063133-A1 |
| titleOfInvention |
Antisense antiviral compound and method for treating arenavirus infection |
| abstract |
The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009082547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9499583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007265214-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10144762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009099066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006063150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10479996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006269911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785407-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906872-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8129352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11236329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905782-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007066556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020417-B2 |
| priorityDate |
2006-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |